Vanguard Capital Management’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.8M Sell
2,035,477
-48,851
-2% -$1.04M ﹤0.01% 2033
2026
Q2
$38.4M Buy
2,084,328
+651,048
+45% +$9.9M ﹤0.01% 2085
2026
Q1
$25.6M Buy
+1,433,280
New +$20.2M ﹤0.01% 2205

Other funds holding VOR

Vanguard Capital Management's VOR Position: Q3 2026 in Review

Vanguard Capital Management reduced its Vor Biopharma (VOR) stake by 2.3% in Q3 2026, selling an estimated $1.04M and leaving 2,035,477 shares worth $38.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Vanguard Capital Management first reported a position in VOR in Q1 2026 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Vanguard Capital Management held 2,035,477 shares of Vor Biopharma worth $38.8M as of Q3 2026.
  • Vanguard Capital Management sold 48,851 Vor Biopharma shares in Q3 2026, an estimated $1.04M.
  • Vor Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2033 holding.
  • Vanguard Capital Management first reported a position in Vor Biopharma in Q1 2026 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.